首页> 外文期刊>Respiratory care >Tailoring Empirical Antimicrobial Therapy in Subjects With Ventilator-Associated Pneumonia With a 10-Hour E-Test Approach
【24h】

Tailoring Empirical Antimicrobial Therapy in Subjects With Ventilator-Associated Pneumonia With a 10-Hour E-Test Approach

机译:用10小时的电子试验方法剪裁呼吸机相关肺炎受试者的经验抗菌疗法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: In a previous study of subjects suspected of having ventilator-associated pneumonia, a rapid susceptibility testing approach by using ETEST (BioMerieux) strips directly applied to bronchoalveolar lavage samples provided valuable information at hour 24. The primary objective of this study was to assess a new direct specimen testing by using an even more-rapid E-test approach (at hour 10), which could promote an early de-escalation of the antimicrobial therapy. METHODS: Twenty-eight subjects with ventilator-associated pneumonia admitted to a medical ICU were prospectively included. In parallel with standard routine methods, E-test strips were directly applied onto agar plates seeded with bronchoalveolar lavage samples and were analyzed after 10 h of incubation. E-test results were used to identify potential drug choices by simulating clinical decision making if the microscopy results had been available at the point of care. These choices were analyzed for concordance with the narrowest adequate antimicrobial therapy according to the Minimum Inhibitory Concentrations (MICs) provided by the reference method (ie, the laboratory routine diagnostic). RESULTS: At hour 10, direct specimen testing was readable in 18 of 28 bronchoalveolar lavage samples (64%). Total agreement between the 10-h direct specimen testing approach and the laboratory routine diagnostic approach was 90%, with a sensitivity of 83% and a specificity of 95%, with 8% major errors and 3% very major errors. The concordance between the 2 tests was very good (kappa = 0.79). If the 10-h E-test results were taken into account, then an early de-escalation strategy would have been possible in 10 of 18 cases (55%) at hour 10. CONCLUSIONS: This rapid susceptibility testing approach provided early (10 h) and valuable information that could lead to an early adjustment of empirical antimicrobial treatment in a ventilator-associated pneumonia setting.
机译:背景:在先前涉及呼吸机相关肺炎的受试者的研究中,通过使用ETEST(BioMerieux)的快速敏感性测试方法直接应用于支气管肺泡灌洗样品,每小时提供有价值的信息。本研究的主要目标是评估通过使用甚至更快速的电子测试方法(在10小时)的新直接标本测试,这可以促进抗微生物治疗的早期脱升升级。方法:预先包括二十八名呼吸机相关肺炎的呼吸机相关肺炎。与标准常规方法平行,将E-Tes​​t STRIPS直接施加到用支气管肺泡灌洗样品接种的琼脂平板上,并在孵育10小时后进行分析。通过模拟在护理点可用的显微镜​​结果,通过模拟临床决策来识别潜在的药物选择。根据参考方法(即实验室常规诊断)提供的最小抑制浓度(MIC),分析了这些选择以进行一致性。结果:10小时,直接试样检测可在28个支气管肺泡灌洗样品(64%)中可读。 10-H直接试样测试方法与实验室常规诊断方法之间的总协议为90%,灵敏度为83%,特异性为95%,具有8%的主要误差和3%非常严重的错误。 2测试之间的一致性非常好(Kappa = 0.79)。如果考虑到10-H e-Test结果,那么早期的脱升策略将在18例(55%)时可能在10小时内进行10分。结论:这种快速的易感性测试方法提前(10小时)和有价值的信息,可能导致在呼吸机相关的肺炎环境中早期调整经验抗微生物治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号